Knight Kevin, Badamgarav Enkhe, Henning James M, Hasselblad Vic, Gano Anacleto D, Ofman Joshua J, Weingarten Scott R
Phar, LLC, Los Angeles, CA 90025, USA.
Am J Manag Care. 2005 Apr;11(4):242-50.
To systematically evaluate and synthesize published evidence regarding the effect of disease management programs for patients with diabetes mellitus on processes and outcomes of care.
Systematic literature review and meta-analysis.
Computerized databases were searched for English-language controlled studies assessing the effect of diabetes disease management programs published from 1987 to 2001. Two reviewers extracted study data using a structured abstraction form. Pooled estimates of program effects on glycated hemoglobin were calculated using an empirical Bayes model.
The pooled estimate of program effects on glycated hemoglobin was a 0.5-percentage point reduction (95% confidence interval, 0.3 to 0.6 percentage points), a modest but significant improvement. Evidence also supports program benefits in improving screening for retinopathy and foot lesions.
Diabetes disease management programs can improve glycemic control to a modest extent and can increase screening for retinopathy and foot complications. Further efforts will be required to create more effective disease management programs for patients with diabetes mellitus.
系统评价并综合已发表的关于糖尿病患者疾病管理项目对医疗过程及结局影响的证据。
系统文献综述和荟萃分析。
检索计算机化数据库,查找1987年至2001年发表的评估糖尿病疾病管理项目效果的英文对照研究。两名研究者使用结构化摘要表格提取研究数据。使用经验贝叶斯模型计算项目对糖化血红蛋白影响的合并估计值。
项目对糖化血红蛋白影响的合并估计值为降低0.5个百分点(95%置信区间为0.3至0.6个百分点),虽幅度不大但有显著改善。有证据支持项目在改善视网膜病变和足部病变筛查方面的益处。
糖尿病疾病管理项目可在一定程度上改善血糖控制,并可增加视网膜病变和足部并发症的筛查。需要进一步努力为糖尿病患者创建更有效的疾病管理项目。